Robert Jackson
Private Equity Investor bei Hildred Capital Management LLC
Profil
Robert “Bob” Jackson is an Operating Partner for Hildred Capital Management (HCM) and has been associated with HCM since 2018.
Mr. Jackson is responsible for evaluating and managing private investment opportunities from a regulatory, manufacturing, and operations perspective.
He is currently serving as the Chief Operating Officer for Pii, an HCM investment company specializing in Contract Development & Manufacturing Organization for branded and generic pharmaceuticals.
Mr Jackson has also been closely involved with several other Hildred portfolio companies, including Crown Laboratories and Project Natural.
Mr. Jackson is the previous President of Global Innovative Product Development of Glenmark Pharmaceuticals, Inc. ("Glenmark”).
Prior to Glenmark, Mr. Jackson served as Executive Vice President of Manufacturing Operations at Forest Labs.
In his 14 years at Forest Labs, Mr. Jackson held a variety of positions with Research & Development ultimately being responsible for global drug product manufacturing at both internal (facilities in Dublin, Ireland and Cincinnati, USA) and external manufacturing sites located across the globe.
Prior to Forest Labs, Mr. Jackson worked at Novartis in both Corporate Project Management and Research.
Bob and his wife Jane reside in Madison, NJ.
They have a son and daughter both graduates of the University of Miami.
Bob’s interests include spending extended time on a beach, skiing, and trying to improve his golf game.
Aktive Positionen von Robert Jackson
Unternehmen | Position | Beginn |
---|---|---|
Hildred Capital Management LLC
Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Private Equity Investor | 01.01.2018 |
Ehemalige bekannte Positionen von Robert Jackson
Unternehmen | Position | Ende |
---|---|---|
GLENMARK PHARMACEUTICALS LIMITED | Präsident | 31.12.2018 |
FOREST LABORATORIES, INC. | Corporate Officer/Principal | 31.12.2014 |
NOVARTIS AG | Corporate Officer/Principal | 31.12.2000 |
Ausbildung von Robert Jackson
University of Lynchburg | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NOVARTIS AG | Health Technology |
GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Hildred Capital Management LLC
Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Finance |